百合地黄汤治疗癌症相关性抑郁症的研究进展  

Research Progress of Lily Dihuang Decoction in the Treatment of Cancer-Related Depression

作　　者：赵耕民 刘松江[2] 

机构地区：[1]黑龙江中医药大学研究生院,黑龙江 哈尔滨 [2]黑龙江中医药大学附属第一医院肿瘤科,黑龙江 哈尔滨

出　　处：《临床个性化医学》2024年第4期1323-1329,共7页Journal of Clinical Personalized Medicine

摘　　要：癌症目前已是世界上危害人类健康排名第二的疾病,其发病率和死亡率居高不下。伴随着癌症患者的常见并发症包括抑郁,焦虑等,抑郁症给患者身心带来巨大的伤害。百合地黄汤作为经方之一,在肿瘤相关性抑郁上具有促进单胺神经递质释放,抑制单胺氧化酶活性,抑制HPA轴活性,抗炎,保护神经的疗效。本研究对于百合地黄汤对于肿瘤相关性抑郁症的实验研究与临床研究进行综述,盼能对肿瘤相关性抑郁症的治疗与研究有进益之处。Cancer is currently the second most dangerous disease in the world, and its morbidity and mortality remain high. Common complications that accompany cancer patients include depression, anxiety, etc., and depression brings great harm to the patient’s body and mind. As one of the formulas, Lily Dihuang decoction has the effects of promoting the release of monoamine neurotransmitters, inhibiting monoamine oxidase activity, inhibiting HPA axis activity, anti-inflammatory, and protecting nerves in tumor-related depression. This study reviews the experimental and clinical studies of Lily Dihuang decoction on tumor-related depression, hoping to make progress in the treatment and research of tumor-related depression.

关 键 词：抑郁症 单胺神经递质 单胺氧化酶 下丘脑–垂体–肾上腺轴 研究进展 

分 类 号：R73[医药卫生—肿瘤]